Department of Pathology and Microbiology, Atlantic Veterinary College, University of Prince Edward Island, 550 University Avenue, Charlottetown, PE C1A 4P3, Canada.
Department of Pathology and Microbiology, Atlantic Veterinary College, University of Prince Edward Island, 550 University Avenue, Charlottetown, PE C1A 4P3, Canada.
Int J Parasitol. 2020 Sep;50(10-11):873-889. doi: 10.1016/j.ijpara.2020.06.007. Epub 2020 Jul 31.
Treatment of infestation by the ectoparasite Lepeophtheirus salmonis relies on a small number of chemotherapeutant treatments that currently meet with limited success. Drugs targeting chitin synthesis have been largely successful against terrestrial parasites where the pathway is well characterised. However, a comparable approach against salmon lice has been, until recently, less successful, likely due to a poor understanding of the chitin synthesis pathway. Post-transcriptional silencing of genes by RNA interference (RNAi) is a powerful method for evaluation of protein function in non-model organisms and has been successfully applied to the salmon louse. In the present study, putative genes coding for enzymes involved in L. salmonis chitin synthesis were characterised after knockdown by RNAi. Nauplii I stage L. salmonis were exposed to double-stranded (ds) RNA specific for several putative non-redundant points in the pathway: glutamine: fructose-6-phosphate aminotransferase (LsGFAT), UDP-N-acetylglucosamine pyrophosphorylase (LsUAP), N-acetylglucosamine phosphate mutase (LsAGM), chitin synthase 1 (LsCHS1), and chitin synthase 2 (LsCHS2). Additionally, we targeted three putative chitin deacetylases (LsCDA4557, 5169 and 5956) by knockdown. Successful knockdown was determined after moulting to the copepodite stage by real-time quantitative PCR (RT-qPCR), while infectivity potential (the number of attached chalimus II compared with the initial number of larvae in the system) was measured after exposure to Atlantic salmon and subsequent development on their host. Compared with controls, infectivity potential was not compromised in dsAGM, dsCHS2, dsCDA4557, or dsCDA5169 groups. In contrast, there was a significant effect in the dsUAP-treated group. However, of most interest was the treatment with dsGFAT, dsCHS1, dsCHS1+2, and dsCDA5956, which resulted in complete abrogation of infectivity, despite apparent compensatory mechanisms in the chitin synthesis pathway as detected by qPCR. There appeared to be a common phenotypic effect in these groups, characterised by significant aberrations in appendage morphology and an inability to swim. Ultrastructurally, dsGFAT showed a significantly distorted procuticle without distinct exo/endocuticle and intermittent electron dense (i.e. chitin) inclusions, and together with dsUAP and dsCHS1, indicated delayed entry to the pre-moult phase.
对体外寄生虫鲑虱的治疗依赖于少数几种化学治疗药物,但目前这些药物的疗效有限。靶向几丁质合成的药物在陆地寄生虫中已取得很大成功,因为这些寄生虫的几丁质合成途径已经得到充分的描述。然而,直到最近,针对鲑虱的类似方法却收效甚微,这可能是因为对几丁质合成途径的了解不足。通过 RNA 干扰(RNAi)对基因进行转录后沉默是评估非模式生物中蛋白质功能的一种强大方法,已成功应用于鲑虱。在本研究中,通过 RNAi 敲低后,对参与鲑虱几丁质合成的假定基因进行了特征描述。处于第一期无节幼体阶段的鲑虱被暴露于双链 RNA(dsRNA)中,该 dsRNA 针对该途径中的几个假定非冗余点:谷氨酰胺:果糖-6-磷酸氨基转移酶(LsGFAT)、UDP-N-乙酰葡萄糖胺焦磷酸化酶(LsUAP)、N-乙酰葡萄糖胺磷酸变位酶(LsAGM)、几丁质合酶 1(LsCHS1)和几丁质合酶 2(LsCHS2)。此外,我们还通过敲低来靶向三个假定的几丁质脱乙酰酶(LsCDA4557、5169 和 5956)。通过实时定量 PCR(RT-qPCR)在蜕皮到桡足幼体阶段后确定成功敲低,然后通过暴露于大西洋鲑鱼并在其宿主上随后发育来测量感染潜力(与系统中初始幼虫数量相比附着的第二龄幼虫 chalimus II 的数量)。与对照组相比,dsAGM、dsCHS2、dsCDA4557 或 dsCDA5169 组的感染潜力并未受到损害。相比之下,dsUAP 处理组则有显著影响。然而,最引人注目的是 dsGFAT、dsCHS1、dsCHS1+2 和 dsCDA5956 的治疗效果,尽管 qPCR 检测到几丁质合成途径中存在明显的补偿机制,但这些治疗组的感染能力完全被阻断。在这些组中出现了一种共同的表型效应,其特征是附肢形态的显著异常以及无法游泳。超微结构观察表明,dsGFAT 显示出明显变形的前角质层,没有明显的外/内角质层和间断的电子致密(即几丁质)内含物,与 dsUAP 和 dsCHS1 一起,表明进入预蜕皮阶段延迟。